The Perelman School of Medicine at the University of
Pennsylvania and ViralEd, Inc. are proud to present the "Hepatitis Grand
Rounds" 2019 series. Formerly the "Viral Hepatitis Grand Rounds", this program is modeled
on the ground-breaking CME activity "HIV Grand Rounds," which, in
partnership with the Perelman School of Medicine at the University of
Pennsylvania, is currently in its tenth year. These CME-certified sessions
combine traditional academic grand rounds with the innovation and convenience
of telemedicine. The Hepatitis Grand
Rounds from the Perelman School of Medicine at the University of Pennsylvania
is delivered live via the Internet on two Wednesdays each month at 12:00 pm
Eastern Time and each presentation is available for on-demand viewing immediately
following the live broadcast.
Hepatitis Grand Rounds presentations cover the most important and current
topics in hepatitis, including NASH, HBV and HCV, and are delivered by the top
experts in the field. They are designed to be immediately relevant to
practicing clinicians and many are case-based. The final 10 minutes of each
one-hour educational activity consists of a live question and answer period,
with the presenting faculty member available to answer questions asked by
attendees using the webinar interface. These bi-monthly grand rounds are
intended to provide clinicians with convenient and easily accessible knowledge
and clinical skills they need to provide the best medical care for their hepatitis
patients.
Each session may be broadcast via your Internet connection in your conference
room or auditorium for large groups to view, or individually to your personal
computer at your convenience. Simply register at www.viraled.com/hepatitisgrandrounds for
easy access.
This program has been designed for Family Medicine, Pediatrics, Neurology, Obstetrics And Gynecology, Psychiatry, Internal Medicine - Endocrinology, Diabetes And Metabolism, Internal Medicine - Gastroenterology, Internal Medicine - Infectious Disease, Internal Medicine - Transplant Hepatology
Hepatitis Grand Rounds is supported by educational grants from Gilead Sciences Medical Affairs and Intercept Pharmaceuticals, Inc.
After completing this activity, participants should be better able to:
|
David E. Kaplan, MD, MSc
K. Rajender Reddy, MD Raymond Soccio, MD Assistant Professor of Medicine Division of Endocrinology, Diabetes and Metabolism Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania |
The Next Presentation of Hepatitis Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania will be:
Speaker: A. Sidney Barritt IV, MD, MSCR
Topic: Emerging data on the impact of COVID-19 in chronic liver disease and liver transplantation
Presented live at 12:00 PM ET, bi-weekly on Wednesdays and anytime On-Demand
If CME credit is desired for any of the live sessions, proceed to https://upenn.cloud-cme.com to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.
You will need Internet to participate in this activity.
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses/Pharmacists: This activity is not approved for nursing or pharmacy contact hours
PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.
It is policy at Penn Medicine Office of Continuing Medical and Interprofessional Education for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose, we consider relationships of the person involved to include financial relationships of a spouse or partner.
The intent of this policy is to ensure that Penn CME/CE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of Continuing Medical and Interprofessional Education (CME and IPCE) have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity. Any peer reviewer with a potential conflict of interest will recuse themselves from the peer review process.
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
|
Planning Committee Members:
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
|
K. Rajender Reddy, MD (Program Co-Chair)
David Kaplan, MD (Program Co-Chair)
|
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside DA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
